Researcher Kalyan C. Nagulapalli Venkata

Dr. Kalyan C. Nagulapalli Venkata is a distinguished researcher and academician known for his groundbreaking contributions to medicinal chemistry. With a diverse educational background and extensive experience in both academia and the pharmaceutical industry, Dr. Venkata is at the forefront of innovative drug design and development.


Kalyan C. Nagulapalli Venkata
  • Ph.D. in Medicinal Chemistry, University of Southern California, Los Angeles, CA
  • M.S. in Chemistry, Illinois State University, Normal, IL
  • Bachelor of Pharmacy, Osmania University, Hyderabad, India

Professional Journey

Dr. Venkata began his academic journey with a Bachelor of Pharmacy degree from Osmania University, India.

He then pursued his passion for chemistry by obtaining an M.S. in Chemistry from Illinois State University, specializing in Heterocyclic Chemistry.

Subsequently, he earned his Ph.D. in Medicinal Chemistry from the University of Southern California, where he focused on drug design and the development of anti-inflammatory agents, particularly novel lipid mediators.

After completing his doctoral studies, Dr. Venkata transitioned to the pharmaceutical industry, where he served as a senior research scientist at AMRI, Albany, NY.

In this role, he played a key role in the development of late-stage cardiovascular drugs for the treatment of stroke and cardiac arrhythmias.

Currently, he serves as a Postdoctoral Research Associate at the University of Southern California, where he continues to pursue his research interests in organic synthesis and drug design.

Research Focus

Dr. Venkata's research is focused on integrating advanced computational methods with synthetic organic chemistry to design and develop novel agents for the treatment of drug-resistant bacterial infections, cancer, and insulin resistance disorders such as diabetes, obesity, and polycystic ovarian syndrome. His primary research interests include:

  • Synthesis of potent anti-inflammatory and anti-cancer biomolecules, including lipoxins and resolvins.
  • Development of synthetic anti-cancer agents targeting various oncogenic signaling pathways.
  • Investigation of natural products for their potential therapeutic benefits in disease prevention and health promotion.
  • A small plant with big benefits: Fenugreek (Trigonella foenum-graecum Linn.) for disease prevention and health promotion.

Notable Contributions

Dr. Venkata's research has led to numerous high-impact publications and accolades, including the New Investigator Award from the American Association of Colleges of Pharmacy in 2020.

He has made significant contributions to understanding the molecular targets underlying the anticancer effects of natural compounds such as quercetin, curcumin, and pomegranate bioactive constituents.

Additionally, his work on the design and synthesis of novel mimetics of lipoxins and aspirin-triggered lipoxins has paved the way for the development of promising anti-inflammatory agents.

Professional Affiliations and Awards

  • Member of professional bodies such as the American Association of Colleges of Pharmacy and the European Society of Pathology
  • Recipient of the Burg Foundation Postdoctoral Teaching Award from the
  • Department of Chemistry, University of Southern California
  • Harold Moulton Fellowship recipient for outstanding research at the University of Southern California

Social Profiles

Dr. Venkata's interdisciplinary approach to drug discovery and his commitment to scientific excellence continue to drive advancements in the field of medicinal chemistry, with the potential to transform the landscape of modern medicine.

Disclaimer: The researcher(s) associated with the article or study referenced herein are independent individuals and are not employed or affiliated with Vinatura Supplements LLC. Their involvement in the study does not imply endorsement or affiliation with Vinatura Supplements LLC. The views, opinions, and findings expressed in the research are solely those of the researcher(s) and do not necessarily reflect the views or positions of Vinatura Supplements LLC.

Back to blog